When should tuberculosis treatment be stopped if the patient develops transaminitis?

When to Stop TB Treatment for Transaminitis

Stop rifampicin, isoniazid, and pyrazinamide immediately if AST/ALT rises to 5 times the upper limit of normal OR if bilirubin rises above normal, regardless of symptoms. 1

Algorithmic Approach to TB Drug-Induced Transaminitis

Initial Assessment Thresholds

The decision to stop TB treatment depends on the degree of transaminase elevation and presence of symptoms:

Mild Elevation (AST/ALT <2x ULN):

• Continue all TB medications
• Repeat liver function tests at 2 weeks
• If levels have fallen, only repeat for symptoms
• If levels rise above 2x ULN on repeat, escalate monitoring 1

Moderate Elevation (AST/ALT 2-5x ULN):

• Continue all TB medications
• Monitor liver function weekly for 2 weeks, then every 2 weeks until normalized
• Do NOT stop treatment at this level 1

Severe Elevation - STOP TREATMENT:

• AST/ALT ≥5x ULN (asymptomatic patient) 1
• AST/ALT ≥3x ULN with hepatitis symptoms (fever, malaise, vomiting, jaundice) 2, 3
• Any bilirubin elevation above normal range (with or without symptoms) 1, 4

Management After Stopping Hepatotoxic Drugs

For Non-Infectious or Stable TB:

• If patient is not unwell and TB is non-infectious, no treatment is needed until liver function normalizes 1

For Infectious or Severe TB:

• If patient is unwell OR sputum smear-positive within 2 weeks of starting treatment, continue treatment with non-hepatotoxic drugs
• Use streptomycin and ethambutol (with appropriate renal and visual monitoring) unless contraindicated or drug resistance suspected 1
• Consider adding fluoroquinolones or other reserve drugs, accounting for their hepatotoxicity potential 1

Drug Reintroduction Protocol

Once liver function normalizes (AST/ALT <2x ULN), reintroduce drugs sequentially in this specific order:

1. Isoniazid first: Start 50 mg/day, increase to 300 mg/day over 2-3 days if no reaction
2. Rifampicin second: After 2-3 days without reaction, start 75 mg/day, increase to 300 mg after 2-3 days, then to 450 mg (<50 kg) or 600 mg (>50 kg) after another 2-3 days
3. Pyrazinamide last: Start 250 mg/day, increase to 1.0 g after 2-3 days, then to 1.5 g (<50 kg) or 2.0 g (>50 kg) 1

Monitor liver function and clinical condition daily during reintroduction 1

Important Caveats

Never add a single drug to a failing regimen - this creates de facto monotherapy and risks developing resistance. Always add ≥2 drugs when modifying treatment 5

Modest transaminase elevations are common in TB patients even before treatment starts, so baseline testing is essential 1

Recent evidence suggests higher thresholds may be safe: A 2026 randomized trial in tuberculous meningitis found that continuing all drugs unless ALT ≥10x ULN (rather than the traditional 5x ULN) appeared safe and reduced rifampicin/isoniazid interruptions without causing liver failure 6. However, this was specific to meningitis patients and requires expert consultation before applying broadly.

If pyrazinamide is identified as the offending drug after sequential reintroduction, extend total treatment duration to 9 months with rifampicin and isoniazid, supplemented with ethambutol for the initial 2 months 1

Exclude other causes: Test for hepatitis A, B, and C viruses if not done at baseline, and carefully assess for alcohol use and other hepatotoxins 2